The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

Cardiovascular-kidney-metabolic (CKM) disease - where heart disease, kidney disease, diabetes, and obesity co-exist and ...

A multicenter study reveals that invasive mechanical ventilation increases the risk of acute kidney injury in critically ill ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

IN line with President Ferdinand Marcos, Jr.'s assurance of continuous expansion in health care benefits despite zero subsidy ...

IN A major win for dialysis patients, the Philippine Health Insurance Corp. (PhilHealth) has significantly enhanced its Z ...

In line with President Ferdinand Marcos Jr.'s assurance of continuous expansion in healthcare benefits despite zero subsidy, the Philippine Health Insurance Corporation (PhilHealth) has substantially ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q®NETs H3.1 biomarker is an ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

The Philippine Health Insurance Corporation (PhilHealth) has expanded the Z Benefit package for Peritoneal Dialysis (PD) with ...